Departmental Affiliations
Center & Institute Affiliations
Isabelle Coppens, PhD, MSc, studies how intracellular apicomplexan parasites exploit the resources of their host cells, to expose the parasite’s vulnerabilities.
Contact Info
615 N. Wolfe Street, Room E5648
Baltimore
Maryland
21205
US
410-955-0105
Research Interests
Toxoplasma;
Plasmodium liver stage;
Cryptosporidium;
host cell-parasite interactions;
parasitophorous vacuole;
nutrient uptake;
lipids;
cholesterol
cell biology
drug targeting
Additional Links
Experiences & Accomplishments
Education
MSc
University of Lille
1993
PhD
University of Louvain
1988
Overview
OBLIGATORY INTRACELLULAR PARASITISM: BIOLOGICAL ADAPTATIONS OF APICOMPLEXA INSIDE MAMMALIAN CELLS
Toxoplasma gondii, a leading opportunistic pathogen in immunosuppressive conditions, is an intracellular protozoan that must live in a membrane-bound compartment in mammalian cells in order to survive. By entering into the confines of a cell, Toxoplasma, like its cousin apicomplexan parasite Plasmodium that is responsible for malaria, assures itself a ready source of nutrients and protection from immune confrontations. This luxury crucially relies upon the successful entry into a target cell and avoidance of host cell defenses such as acidification or endo-lysosomal hydrolases. Unarguably, Apicomplexa are highly competent to establish a nonfusiogenic parasitophorous vacuole (PV) that provides a balance between the subversion of host defenses and the parasite's anabolic needs.
Our current interest is in studying the strategies used by T. gondii and Plasmodium to exploit host cell resources and disarm host cell defenses. Because of the abundance of organic molecules within mammalian cells, Apicomplexa have lost many genes required for the biosynthesis of vital components. In return, novel genes promoting host nutrient scavenging have become essential, and these genetic replacements are a successful scenario in order to achieve pathogenicity. By initially focusing on the dependency of Toxoplasma for host lipids, we discovered that this pathogen critically relies on cholesterol derived from plasma lipoproteins. Interference with low-density lipoprotein endocytosis or cholesterol translocation from lysosomes arrests parasite development. My group has next uncovered the mechanisms of cholesterol delivery from host endocytic compartments to the PV.
Unexpectedly, Toxoplasma can sequester nutrient-filled host lysosomes within invaginations of the PV membrane, which allows access to components supplied by the endocytic network. These observations have refuted the previous dogma asserting the complete seclusion of the PV from the host vesicular transport system and identify a unique mechanism for unidirectional transport of mammalian organelles. In the long term, we will decipher the microbial genes and pathways involved in the co-option of host cell processes and organelles by T. gondii.
These studies are extended to the malaria parasite, and more precisely to the stage infecting hepatocytes. Indeed, although the Plasmodium liver forms achieve one of the fastest growth rates among all organisms, nothing is known about Plasmodium-hepatocyte interactions. An exciting possibility is that the pathogenic mechanisms underlying the remarkable host-parasite interface might represent targets for the development of therapeutic strategies against Apicomplexa infections.
Of interest, the original features provided by the study of intracellular pathogenesis offer a unique perspective to elucidate basic questions in mammalian cell biology. Indeed as our understanding of the cell biology of Apicomplexa expands, novel and unexpected questions are presented, reaffirming the position of these parasites as a model system. In particular, our research might shed light on the routes of cholesterol trafficking, microtubule dynamics, membrane bilayer deformation and organelle degradation for other biological systems.
Toxoplasma gondii, a leading opportunistic pathogen in immunosuppressive conditions, is an intracellular protozoan that must live in a membrane-bound compartment in mammalian cells in order to survive. By entering into the confines of a cell, Toxoplasma, like its cousin apicomplexan parasite Plasmodium that is responsible for malaria, assures itself a ready source of nutrients and protection from immune confrontations. This luxury crucially relies upon the successful entry into a target cell and avoidance of host cell defenses such as acidification or endo-lysosomal hydrolases. Unarguably, Apicomplexa are highly competent to establish a nonfusiogenic parasitophorous vacuole (PV) that provides a balance between the subversion of host defenses and the parasite's anabolic needs.
Our current interest is in studying the strategies used by T. gondii and Plasmodium to exploit host cell resources and disarm host cell defenses. Because of the abundance of organic molecules within mammalian cells, Apicomplexa have lost many genes required for the biosynthesis of vital components. In return, novel genes promoting host nutrient scavenging have become essential, and these genetic replacements are a successful scenario in order to achieve pathogenicity. By initially focusing on the dependency of Toxoplasma for host lipids, we discovered that this pathogen critically relies on cholesterol derived from plasma lipoproteins. Interference with low-density lipoprotein endocytosis or cholesterol translocation from lysosomes arrests parasite development. My group has next uncovered the mechanisms of cholesterol delivery from host endocytic compartments to the PV.
Unexpectedly, Toxoplasma can sequester nutrient-filled host lysosomes within invaginations of the PV membrane, which allows access to components supplied by the endocytic network. These observations have refuted the previous dogma asserting the complete seclusion of the PV from the host vesicular transport system and identify a unique mechanism for unidirectional transport of mammalian organelles. In the long term, we will decipher the microbial genes and pathways involved in the co-option of host cell processes and organelles by T. gondii.
These studies are extended to the malaria parasite, and more precisely to the stage infecting hepatocytes. Indeed, although the Plasmodium liver forms achieve one of the fastest growth rates among all organisms, nothing is known about Plasmodium-hepatocyte interactions. An exciting possibility is that the pathogenic mechanisms underlying the remarkable host-parasite interface might represent targets for the development of therapeutic strategies against Apicomplexa infections.
Of interest, the original features provided by the study of intracellular pathogenesis offer a unique perspective to elucidate basic questions in mammalian cell biology. Indeed as our understanding of the cell biology of Apicomplexa expands, novel and unexpected questions are presented, reaffirming the position of these parasites as a model system. In particular, our research might shed light on the routes of cholesterol trafficking, microtubule dynamics, membrane bilayer deformation and organelle degradation for other biological systems.
Honors & Awards
Faculty Innovation award from the Johns Hopkins University School of Public Health (2004) European Community Postdoctoral Research Award (1995) Prize from the French Rhône-Poulenc Rorer Foundation (1992) Prize of Pierre-J. & Edouard van Beneden from the Belgian Royal Academy of Sciences (1990) University of Louvain Research Award from the National Funds for Scientific Research (1989) University of Louvain Research Award from the National Funds for Scientific Research (1987) WHO Special Program for Research and Training in Tropical Disease Scholarship (1986) Institute for Scientific Research for Industry and Agriculture Encouragement Scholarship (1983)
Select Publications
Some reviews below reflective of the Coppens lab:
-Coppens I, Romano JD (2018) Hostile intruder: Toxoplasma holds host organelles captive. PLoS Pathog. 14:e1006893.
- Coppens I. (2017) How Toxoplasma and malaria parasites defy first, then exploit host autophagic and endocytic pathways for growth. Curr Opin Microbiol. 40:32-39.
- Coppens I. (2014) Exploitation of auxotrophies and metabolic defects in Toxoplasma as therapeutic approaches. Int. J. Parasitol. 44:109-120.
- Coppens I. (2013) Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat. Rev. Microbiol. 11:823-835.
- Romano JD, Coppens I.(2013) Host Organelle Hijackers: a similar modus operandi for Toxoplasma gondii and Chlamydia trachomatis: co-infection model as a tool to investigate pathogenesis. Pathog Dis. 69:72-86.
- Coppens I.(2011) Metamorphoses of malaria: the role of autophagy in parasite differentiation.Essays Biochem. 51:127-36.
- Coppens I.(2006) Contribution of host lipids to Toxoplasma pathogenesis. Cell. Microbiol. 8:1-9.
- Romano JD, Nolan SJ, Porter C, Ehrenman K, Hartman EJ, Hsia RC, Coppens I. The parasite Toxoplasma sequesters diverse Rab host vesicles within an intravacuolar network. J. Cell Biol. 216:4235-4254. https://www.ncbi.nlm.nih.gov/pubmed/?term=nolan+coppens+romano
- Nolan SJ, Romano JD, Coppens I. (2017) Host lipid droplets: An important source of lipids salvaged by the intracellular parasite Toxoplasma gondii. PLoS Pathog. 13:e1006362. https://www.ncbi.nlm.nih.gov/pubmed/28570716
- Voss C, Ehrenman K, Mlambo G, Mishra S, Kumar KA, Sacci JB Jr, Sinnis P, Coppens I. (2016) Overexpression of Plasmodium berghei ATG8 by Liver Forms Leads to Cumulative Defects in Organelle Dynamics and to Generation of Noninfectious Merozoites. MBio 7:e00682-16. https://www.ncbi.nlm.nih.gov/pubmed/27353755
- Romano J, Sonda S, Bergbower E, Smith ME and Coppens I (2013) Toxoplasma gondii salvages sphingolipids from the host Golgi through the rerouting of selected Rab vesicles to the parasitophorous vacuole. Mol. Biol. Cell 24:1974-1995. https://www.ncbi.nlm.nih.gov/pubmed/23615442
- Coppens I, Dunn JD, Romano JD, Pypaert M, Zhang H, Boothrod JC and Joiner KA (2006) Toxoplasma sequesters host lysosomes in the vacuolar space. Cell 125:261-274. https://www.ncbi.nlm.nih.gov/pubmed/16630815